An operation that targets the nerves connected to the kidney has been found to significantly reduce blood pressure in patients with hypertension, according to the results of a clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust, and supported by the National Institute for Health Research (NIHR).
If the findings are confirmed in more extensive clinical trials, the surgery could offer hope to patients with high blood pressure who do not respond to drugs, and are at increased risk of cardiovascular diseases, including stroke and heart attack.
The international clinical trial, carried out from 2017 to 2018 at St Bartholomew’s Hospital in the UK by the NIHRBarts Biomedical Research Centre, tested a one-hour operation called ‘renal denervation’, which uses ultrasound energy to disrupt the nerves between the kidneys and the brain that carry signals for controlling blood pressure.
Significant reduction in blood pressure
146 patients in the United States, France, Germany, the Netherlands, Belgium and the United Kingdom were randomised to receive either renal denervation or a ‘sham procedure’ – the surgical equivalent of a placebo. Patients also remained off blood pressure medications for two months unless specified blood pressure levels were exceeded.
After two months, the renal denervation group experienced an 8.5 mm Hg reduction in blood pressure, which was a 6.3 mm Hg greater reduction compared with the sham group.
More than 66 per cent of subjects treated with renal denervation demonstrated a 5 mm Hg or greater reduction in blood pressure, compared with 33 per cent in the sham group.
No major adverse events were reported in either group, and the blood pressure lowering effect of renal denervation was consistent across sex and ethnicity.
An alternative to lifelong medications
UK Principal Investigator Dr Melvin Lobo from Queen Mary’s William Harvey Research Institute and Barts Health NHS Trust said: “These results leave us clinicians in no doubt that this ultrasound-based therapy works to improve blood pressure control – at least in the short term. Further larger trials will be needed to confirm the efficacy and safety of the technology, but we hope that they could lead to renal denervation therapy being offered as an alternative to lifelong medications for hypertension.”
The study has limitations including the short follow-up time of two months. This was done for safety reasons to minimise the duration of patients being off antihypertensive medications. Longer follow-up of this trial and additional numbers of treated patients will be necessary to provide greater assurance of safety and to exclude rare adverse events.
The Latest on: Hypertension
via Google News
The Latest on: Hypertension
- Hypertension Management Devices Market Size Growth, Share, Merger, Key Companies, CAGR Status by 2028on June 10, 2021 at 2:01 pm
The scope of the report includes a detailed study of Hypertension Management Devices Market with the reasons given for variations in the growth of the industry in certain regions. The Hypertension ...
- High Blood Pressure Drugs (Hypertension) Market Size, Share, Trends, Analysis and Forecast 2027on June 9, 2021 at 7:35 am
The report on High Blood Pressure Drugs (Hypertension) provides the clients with a comprehensive analysis of crucial driving factors, consumer behavior, growth trends, product utilization, key player ...
- Pulmonary Arterial Hypertension (PAH) Market Revenue, Industry Growing Demand, Top Companies, Regional Outlook Up To 2027on June 9, 2021 at 1:40 am
The Pulmonary Arterial Hypertension PAH Market is expected to gain market growth in the forecast period of 2021 to 2027 The market is growing with a CAGR of 8 in the forecast period of 2021 to 2027 ...
- ‘Diet, lifestyle modification vital in managing hypertension’on June 8, 2021 at 6:41 pm
Simeon Isezuo, has advocated diet and lifestyle modification as part of the treatment regimen to control hypertension. Isezuo said this during a webinar organised by Neimeth International ...
- High blood pressure: Two signs found on your face warning of hypertension riskon June 8, 2021 at 8:49 am
HIGH blood pressure is sometimes referred to as hypertension and relates to the amount of blood the heart pumps with any resistance. The condition can be a serious matter if readings are not in check.
- Doctors Are Shocked by Anti-Hypertensive Therapy That Reverses Hypertension, Normalize BP, Avoid Heart Attack And Get Rid Of HBP in few weeks!on June 8, 2021 at 6:46 am
Doctors Are Shocked by Anti-Hypertensive Therapy That Reverses Hypertension, Normalize BP, Avoid Heart Attack And Get Rid Of HBP in few weeks! If you’re tired ...
- Researchers Develop a Non-invasive Sensor That Detects Intracranial Hypertensionon June 8, 2021 at 4:25 am
Researchers discovered a new non-invasive sensor that could aid in the development of novel treatments for intracranial Hypertension. The findings are reported in the journal Hypertension .
- High blood pressure: How to tell if you're a 'healthy weight' to avoid hypertensionon June 8, 2021 at 12:54 am
HIGH blood pressure risk could be lowered by making some small changes to your daily life, including your regular diet and exercise routines. It's also important to maintain a 'healthy weight', it's ...
- Discovery offers a potential new pathway to treat hypertensionon June 7, 2021 at 4:48 pm
High blood pressure, or hypertension, is the leading modifiable risk factor for cardiovascular diseases and premature death worldwide.
via Bing News